Speaker illustration

Professor Robert Storey

University of Sheffield, Sheffield (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology

Professor Robert Storey is Professor of Cardiology at the University of Sheffield, Sheffield, UK, where he has headed a thrombosis research group since 2002 and is director of the Cardiovascular Research Unit. He is also Academic Director and honorary Consultant Cardiologist for the Cardiology and Cardiothoracic Surgery Directorate, Sheffield Teaching Hospitals NHS Foundation Trust. He has a special interest in the management of ischaemic heart disease, including acute coronary syndromes and coronary intervention. He was Chair of the ESC Working Group on Thrombosis 2012-14 and has served on several ESC guidelines task forces (chronic coronary syndromes 2019, NSTE ACS 2011 and 2015, dyslipidaemias 2011). He is/has been a member of numerous executive/steering committees for clinical trials in patients with ischaemic heart disease, such as PLATO, PEGASUS-TIMI 54, AUGUSTUS and COMPLETE.

New avenues for combating atherothrombosis

Event: EuroThrombosis and EuroVessels 2022

Topic: Thrombosis, Bleeding

Session type: Teaching Course

Thumbnail

Antithrombotic and anticoagulant therapy

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session type: Moderated ePosters

Thumbnail

Guidelines in Practice: dual antiplatelet therapy (DAPT): a roller coaster ride

Event: ESC Congress 2022

Topic: Treatment

Session type: Guidelines in Practice

Thumbnail

Antithrombotic therapy in patients with acute coronary syndromes

Event: ESC Congress 2019

Topic: Treatment

Session type: Symposium

Thumbnail

Optimising non-vitamin K antagonist oral anticoagulant (NOAC) management in atrial fibrillation and acute coronary syndrome (ACS)/percutaneous coronary intervention (PCI) - Clinical practice perspective

Event: ESC Congress 2019

Topic: Atrial Fibrillation (AF)

Session type: Satellite Symposium - Experts on the Spot

Thumbnail

Controversies in anti-platelet therapy

Event: ESC Congress 2019

Topic: Pharmacotherapy

Session type: Debate Session

Thumbnail

Dual antiplatelet therapy and PCI - Important controversies

Event: ESC Congress 2018

Topic: Antiplatelet Agents

Session type: Debate Session

Thumbnail

Great Debate on STEMI: current controversies on immediate treatment.

Event: Acute Cardiovascular Care 2018

Topic: Miscellaneous

Session type: Debate Session

Thumbnail

ACCA Research Prize

Event: Acute Cardiovascular Care 2016

Topic: Miscellaneous

Session type: Abstract Sessions

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb